Predicting clinical phenotypes of metachromatic leukodystrophy based on the arylsulfatase A activity and the ARSA genotype? – Chances and challengesVidiyaah Santhanakumaran, Lucia Laugwitz, Samuel Groeschel et al.|Molecular Genetics and Metabolism|2022Cited by 43
Newborn screening in metachromatic leukodystrophy – European consensus-based recommendations on clinical managementLucia Laugwitz, Samuel Groeschel, Hanka Dekker et al.|European Journal of Paediatric Neurology|2024Cited by 28
Human COQ4 deficiency: delineating the clinical, metabolic and neuroimaging phenotypesLucia Laugwitz, Felix Distelmaier, Annette Seibt et al.|Journal of Medical Genetics|2021Cited by 27
Newborn Screening and Presymptomatic Treatment of Metachromatic LeukodystrophyLucia Laugwitz, Samuel Groeschel, Thomas P. Mechtler et al.|New England Journal of Medicine|2024Cited by 20
Extremely low arylsulfatase A enzyme activity does not necessarily cause symptoms: A long‐term follow‐up and review of the literatureLucia Laugwitz, Samuel Groeschel, Vidiyaah Santhanakumaran et al.|JIMD Reports|2022Cited by 20